Disparities Seen in Unintentional Firearm Mortality Across U.S. States
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, July 26, 2024 -- There are considerable disparities in the rate of unintentional firearms mortality across the 50 U.S. states and District of Columbia, with the highest rates clustered in the Southeast, according to a study published online June 29 in Injury Prevention.
David C. Schwebel, Ph.D., from the University of Alabama at Birmingham, quantified unintentional firearm-related mortality across the United States and within individual states between 2001 and 2021, and examined five state-level predictors: rurality, non-White population, poverty, population, and gun ownership.
Schwebel notes that the highest unintentional firearm-related mortality rates were clustered in the Southeastern states, followed by the Northern Plains and Mountain West. The Northwest had the lowest rates, followed by scattered states in the West and Midwest. Unintentional firearms mortality at the state level correlated positively with percent below the poverty level, percent of population that is rural, and percent of population owning firearms (r = 0.54, 0.59, and 0.72, respectively). Three factors emerged as significant in a multivariable model predicting unintentional firearms mortality by state: percent White, below the poverty level, and owning firearms (β = −0.22, 0.43, and 0.54, respectively).
"Prevention of unintentional firearms mortality is essential nationwide, but should be targeted especially to vulnerable populations, including those living in states identified by this research to have crude rates that far exceed national averages," Schwebel writes.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-27 07:15
Read more
- How to Choose a Crib Mattress
- Yes, You Can Order Birth Control Online — These Are the 8 Services We…
- Are You a Skin Care Pro?
- Male Birth Control Options
- What Is an Allergic Reaction?
- After Weighting, 3.6 Million Likely to Be Newly Eligible for Semaglutide
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions